Dr. Gregory Scott Brown, MD

Dr. Brown practices at Dialysis Associates in Saginaw, Michigan.

Dr. Brown's NPI, 1568497766, was assigned on July 12, 2006. Dr. Brown holds Michigan license 4301041203.

Dr. Brown's primary practice is Dialysis Associates, at 4848 E McLeod Dr, Saginaw, MI 48604 in Saginaw County. The practice phone is (989) 793-6299.

Dr. Brown's primary practice is Dialysis Associates in Saginaw, Michigan. Dr. Brown is also affiliated with Covenant Medical Center Harrison. The medical group on file is Dialysis Associates PC. Dmand AI also links Dr. Brown to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brown practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Brown's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Brown is licensed in Michigan.

CMS data shows 152 Medicare services from Dr. Brown across 1 procedure code in 2024, for 60 Medicare patients. Medicare paid $24,630 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Brown in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have heart failure, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 3.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brown's median patient age at 70, with 36% women.

In 2024, Dr. Brown wrote 140 Medicare Part D claims for 52 patients. 98% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $312 in total drug cost. In 2023, CMS named 708 claims across 23 drugs.

Dr. Brown accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Brown from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Mallinckrodt Enterprises LLC paid the most, $62.